Imuracetam

From Wikipedia, the free encyclopedia

Imuracetam
Names
Preferred IUPAC name
N,N′-Bis[(2-oxopyrrolidin-1-yl)methyl]urea
Other names
UCB-G218
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
UNII
  • InChI=1S/C11H18N4O3/c16-9-3-1-5-14(9)7-12-11(18)13-8-15-6-2-4-10(15)17/h1-8H2,(H2,12,13,18) checkY
    Key: WMKONRFEZGAHTE-UHFFFAOYSA-N checkY
  • InChI=1/C11H18N4O3/c16-9-3-1-5-14(9)7-12-11(18)13-8-15-6-2-4-10(15)17/h1-8H2,(H2,12,13,18)
    Key: WMKONRFEZGAHTE-UHFFFAOYAT
  • O=C(NCN1C(=O)CCC1)NCN2C(=O)CCC2
Properties
C11H18N4O3
Molar mass 254.290 g·mol−1
Melting point 184.5 °C (364.1 °F; 457.6 K)[1]
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
checkY verify (what is checkY☒N ?)

Imuracetam (INNTooltip International Nonproprietary Name; developmental code name UCB-G218) is a drug of the racetam group described as a nootropic (cognitive enhancer).[2][3] It was under development in the 1970s but was never marketed.[1]

Related Articles

Wikiwand AI